Nicholas S Roetker1, James S Pankow2, Jan Bressler2, Alanna C Morrison2, Eric Boerwinkle2. 1. From the Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis (N.S.R., J.S.P.); Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, University of Texas Health Science Center at Houston (J.B., A.C.M., E.B.); and Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX (E.B.). roetk001@umn.edu. 2. From the Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis (N.S.R., J.S.P.); Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, University of Texas Health Science Center at Houston (J.B., A.C.M., E.B.); and Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX (E.B.).
Abstract
BACKGROUND: DNA methylation-based patterns of biological aging, known as epigenetic age acceleration, are predictive of all-cause mortality, but little is known about their association with cardiovascular disease (CVD). METHODS: We estimated 2 versions of epigenetic age acceleration (Horvath and Hannum) using whole-blood samples from 2543 blacks. Linear and Cox proportional hazards regression, respectively, were used to assess the association of age acceleration with carotid intima-media thickness (cross-sectionally) and incident cardiovascular events, including CVD mortality, myocardial infarction, fatal coronary heart disease, peripheral arterial disease, and heart failure, during a median 21-year follow-up. All models were adjusted for chronological age and traditional CVD risk factors. RESULTS: In comparison to chronological age, the 2 measures of epigenetic age acceleration were weaker, but independent, potential risk markers for subclinical atherosclerosis and most incident cardiovascular outcomes, including fatal coronary heart disease, peripheral arterial disease, and heart failure. For example, each 5-year increment of epigenetic age acceleration was associated with an average of 0.01 mm greater carotid intima-media thickness (each P≤0.01), and the hazard ratios (95% confidence intervals) of fatal coronary heart disease per 5-year increment in Horvath and Hannum age acceleration were 1.17 (1.02-1.33) and 1.22 (1.04-1.44), respectively. CONCLUSIONS: In this sample of blacks, increased epigenetic age acceleration in whole blood was a potential risk marker for incident fatal coronary heart disease, peripheral arterial disease, and heart failure independently of chronological age and traditional CVD risk factors. DNA methylation-based measures of biological aging may help to identify new pathophysiological mechanisms contributing to the development of CVD.
BACKGROUND: DNA methylation-based patterns of biological aging, known as epigenetic age acceleration, are predictive of all-cause mortality, but little is known about their association with cardiovascular disease (CVD). METHODS: We estimated 2 versions of epigenetic age acceleration (Horvath and Hannum) using whole-blood samples from 2543 blacks. Linear and Cox proportional hazards regression, respectively, were used to assess the association of age acceleration with carotid intima-media thickness (cross-sectionally) and incident cardiovascular events, including CVD mortality, myocardial infarction, fatal coronary heart disease, peripheral arterial disease, and heart failure, during a median 21-year follow-up. All models were adjusted for chronological age and traditional CVD risk factors. RESULTS: In comparison to chronological age, the 2 measures of epigenetic age acceleration were weaker, but independent, potential risk markers for subclinical atherosclerosis and most incident cardiovascular outcomes, including fatal coronary heart disease, peripheral arterial disease, and heart failure. For example, each 5-year increment of epigenetic age acceleration was associated with an average of 0.01 mm greater carotid intima-media thickness (each P≤0.01), and the hazard ratios (95% confidence intervals) of fatal coronary heart disease per 5-year increment in Horvath and Hannum age acceleration were 1.17 (1.02-1.33) and 1.22 (1.04-1.44), respectively. CONCLUSIONS: In this sample of blacks, increased epigenetic age acceleration in whole blood was a potential risk marker for incident fatal coronary heart disease, peripheral arterial disease, and heart failure independently of chronological age and traditional CVD risk factors. DNA methylation-based measures of biological aging may help to identify new pathophysiological mechanisms contributing to the development of CVD.
Authors: Ellen W Demerath; Weihua Guan; Megan L Grove; Stella Aslibekyan; Michael Mendelson; Yi-Hui Zhou; Åsa K Hedman; Johanna K Sandling; Li-An Li; Marguerite R Irvin; Degui Zhi; Panos Deloukas; Liming Liang; Chunyu Liu; Jan Bressler; Tim D Spector; Kari North; Yun Li; Devin M Absher; Daniel Levy; Donna K Arnett; Myriam Fornage; James S Pankow; Eric Boerwinkle Journal: Hum Mol Genet Date: 2015-05-01 Impact factor: 6.150
Authors: Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey Journal: N Engl J Med Date: 2012-07-05 Impact factor: 91.245
Authors: Pierre-Antoine Dugué; Julie K Bassett; JiHoon E Joo; Laura Baglietto; Chol-Hee Jung; Ee Ming Wong; Giovanni Fiorito; Daniel Schmidt; Enes Makalic; Shuai Li; Margarita Moreno-Betancur; Daniel D Buchanan; Paolo Vineis; Dallas R English; John L Hopper; Gianluca Severi; Melissa C Southey; Graham G Giles; Roger L Milne Journal: Am J Epidemiol Date: 2018-03-01 Impact factor: 4.897
Authors: Neil Herring; James Cranley; Michael N Lokale; Dan Li; Julia Shanks; Eric N Alston; Beatrice M Girard; Emma Carter; Rodney L Parsons; Beth A Habecker; David J Paterson Journal: J Mol Cell Cardiol Date: 2011-12-07 Impact factor: 5.000
Authors: C Liu; R E Marioni; Å K Hedman; L Pfeiffer; P-C Tsai; L M Reynolds; A C Just; Q Duan; C G Boer; T Tanaka; C E Elks; S Aslibekyan; J A Brody; B Kühnel; C Herder; L M Almli; D Zhi; Y Wang; T Huan; C Yao; M M Mendelson; R Joehanes; L Liang; S-A Love; W Guan; S Shah; A F McRae; A Kretschmer; H Prokisch; K Strauch; A Peters; P M Visscher; N R Wray; X Guo; K L Wiggins; A K Smith; E B Binder; K J Ressler; M R Irvin; D M Absher; D Hernandez; L Ferrucci; S Bandinelli; K Lohman; J Ding; L Trevisi; S Gustafsson; J H Sandling; L Stolk; A G Uitterlinden; I Yet; J E Castillo-Fernandez; T D Spector; J D Schwartz; P Vokonas; L Lind; Y Li; M Fornage; D K Arnett; N J Wareham; N Sotoodehnia; K K Ong; J B J van Meurs; K N Conneely; A A Baccarelli; I J Deary; J T Bell; K E North; Y Liu; M Waldenberger; S J London; E Ingelsson; D Levy Journal: Mol Psychiatry Date: 2016-11-15 Impact factor: 15.992
Authors: Morgan E Levine; H Dean Hosgood; Brian Chen; Devin Absher; Themistocles Assimes; Steve Horvath Journal: Aging (Albany NY) Date: 2015-09 Impact factor: 5.682
Authors: Steve Horvath; Michael Gurven; Morgan E Levine; Benjamin C Trumble; Hillard Kaplan; Hooman Allayee; Beate R Ritz; Brian Chen; Ake T Lu; Tammy M Rickabaugh; Beth D Jamieson; Dianjianyi Sun; Shengxu Li; Wei Chen; Lluis Quintana-Murci; Maud Fagny; Michael S Kobor; Philip S Tsao; Alexander P Reiner; Kerstin L Edlefsen; Devin Absher; Themistocles L Assimes Journal: Genome Biol Date: 2016-08-11 Impact factor: 13.583
Authors: Gina P Sykes; Joseph Kamtchum-Tatuene; Sarina Falcione; Sarah Zehnder; Danielle Munsterman; Boryana Stamova; Bradley P Ander; Frank R Sharp; Glen Jickling Journal: Stroke Date: 2021-03-01 Impact factor: 7.914
Authors: Anat Yaskolka Meir; Maria Keller; Stephan H Bernhart; Ehud Rinott; Gal Tsaban; Hila Zelicha; Alon Kaplan; Dan Schwarzfuchs; Ilan Shelef; Yftach Gepner; Jun Li; Yifei Lin; Matthias Blüher; Uta Ceglarek; Michael Stumvoll; Peter F Stadler; Meir J Stampfer; Peter Kovacs; Liming Liang; Iris Shai Journal: Clin Epigenetics Date: 2021-03-04 Impact factor: 6.551
Authors: Lifang Hou; Donald Lloyd-Jones; Brian T Joyce; Tao Gao; Yinan Zheng; Jiantao Ma; Shih-Jen Hwang; Lei Liu; Drew Nannini; Steve Horvath; Ake T Lu; Norrina Bai Allen; David R Jacobs; Myron Gross; Amy Krefman; Hongyan Ning; Kiang Liu; Cora E Lewis; Pamela J Schreiner; Stephen Sidney; James M Shikany; Daniel Levy; Philip Greenland Journal: Circ Res Date: 2021-08-25 Impact factor: 23.213
Authors: Yevgeniy Gindin; Anuj Gaggar; Anna S Lok; Harry L A Janssen; Carlo Ferrari; G Mani Subramanian; Zhaoshi Jiang; Henry Masur; Benjamin Emmanuel; Bhawna Poonia; Shyam Kottilil Journal: Clin Infect Dis Date: 2021-07-01 Impact factor: 9.079
Authors: Jacqueline D Wright; Aaron R Folsom; Josef Coresh; A Richey Sharrett; David Couper; Lynne E Wagenknecht; Thomas H Mosley; Christie M Ballantyne; Eric A Boerwinkle; Wayne D Rosamond; Gerardo Heiss Journal: J Am Coll Cardiol Date: 2021-06-15 Impact factor: 27.203